Literature DB >> 20813314

Sublobar resection with brachytherapy mesh for stage I non-small cell lung cancer.

David D Odell1, Michael S Kent, Hiran C Fernando.   

Abstract

Lobar resection is currently the standard approach for the treatment of stage I non-small cell lung cancer. Sublobar resection is generally considered a compromise, reserved for high-risk patients because of greater rates of local recurrence compared with lobar resection. Adjuvant radiation therapy may decrease these increased local recurrence rates, but because of respiratory motion and difficulties in identifying the staple line, radiation delivery can be challenging with an external beam approach. Adjuvant intraoperative brachytherapy with the use of low-dose rate iodine-125 seeds placed alongside the surgical staple has been used with success in several centers. A randomized multicenter North American study has also recently completed accrual, but the results of this are not yet available. In the following review, we outline the techniques used, safety considerations, and currently available outcomes of sublobar resection with adjuvant brachytherapy for non-small cell lung cancer. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20813314     DOI: 10.1053/j.semtcvs.2010.04.003

Source DB:  PubMed          Journal:  Semin Thorac Cardiovasc Surg        ISSN: 1043-0679


  5 in total

Review 1.  Local drug delivery strategies for cancer treatment: gels, nanoparticles, polymeric films, rods, and wafers.

Authors:  Jesse B Wolinsky; Yolonda L Colson; Mark W Grinstaff
Journal:  J Control Release       Date:  2011-12-01       Impact factor: 9.776

2.  Iodine-125 brachytherapy improved overall survival of patients with inoperable stage III/IV non-small cell lung cancer versus the conventional radiotherapy.

Authors:  Wei Li; Jing Guan; Lie Yang; Xiushan Zheng; Yongkang Yu; Jianqing Jiang
Journal:  Med Oncol       Date:  2014-11-27       Impact factor: 3.064

3.  Combination of Brachytherapy with Iodine-125 Seeds and Systemic Chemotherapy versus Systemic Chemotherapy Alone for Synchronous Extracranial Oligometastatic Non-Small Cell Lung Cancer.

Authors:  Huzi Li; Zhendong Duan; Cheng Zhao; Wenyan Fang; Yingjie Jia; Xiaojiang Li; Fanming Kong; Lujun Zhao
Journal:  Cancer Manag Res       Date:  2020-09-09       Impact factor: 3.989

4.  125I Seed Brachytherapy Combined with Single-Agent Chemotherapy in the Treatment of Non-Small-Cell Lung Cancer in the Elderly: A Valuable Solution.

Authors:  Tian-Hua Yue; Wei Xing
Journal:  Onco Targets Ther       Date:  2020-10-16       Impact factor: 4.147

5.  Biofunctional core-shell polypyrrole-polyethylenimine nanocomplex for a locally sustained photothermal with reactive oxygen species enhanced therapeutic effect against lung cancer.

Authors:  Chih-Wei Chiang; Er-Yuan Chuang
Journal:  Int J Nanomedicine       Date:  2019-02-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.